The uptake of high-deductible health plans (HDHPs) has accelerated with the state and federal health exchanges under Obamacare. The out-of-pocket costs of these plans, including premium payments, are “consuming far more of total family income than is reasonable,” says Francois de Brantes, executive director of the Healthcare Incentives Improvement. A dilemma, he comments, is that HDHPs are the only way to get premiums down to a level of affordability for many individuals. He believes that until the industry is fully transformed, “It’s not going to get better.”
“It is popular to argue against mandates of any kind,” stresses Arthur Vercillo, MD, FACS, regional president of Excellus Blue Cross Blue Shield, but he strongly recommends that the premiums people pay buy them what amounts to some real insurance—a meaningful minimum benefit package that insurance covers.
Affordability is the key issue, reiterates Mr de Brantes. If the premiums and out-of-pocket costs are 20 to 30% of family income, that’s not affordable or workable.
Large out-of-pocket costs can have negative health consequences, acknowledges Ateev Mehrotra, MD, MPH, associate professor of healthcare policy and medicine at Harvard Medical School and a hospitalist at Beth Israel Deaconess Medical Center. This is especially true for the poor, the elderly, and those with chronic illnesses. In addition, prices for care vary greatly and prospective patients need much more information and transparency about medical care pricing if they are to make intelligent decisions regarding their out-of-pocket costs.
One added advantage that is often overlooked, points out Dr Vercillo, is that when an individual is insured by an exchange plan, they are already getting a negotiated rate for care that is substantially better than what someone without insurance might have to pay.
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
October 30th 2023On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
Listen
SABCS 2023 Sessions Touch on "Every Aspect of Breast Cancer"
December 4th 2023The 46th annual San Antonio Breast Cancer Symposium will take place December 5-9, with new and experienced attendees able to choose and learn from a schedule overflowing with the latest developments in breast cancer science and research.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
NK Cell Therapy SNK01 Improves Cognitive Function in Alzheimer Disease for up to 11 Weeks
December 3rd 2023Among 10 patients evaluated, compared with their baseline at 1 week after receiving their final dose in the trial, 30% demonstrated clinical improvement on the Alzheimer’s disease composite score.
Read More
Health Equity and Access Weekly Roundup: December 2, 2023
December 2nd 2023The Center on Health Equity and Access highlights the most recent updates in the realm of health equity, including news, research findings, and initiatives focused on mitigating health care disparities and enhancing overall access to quality care.
Read More